Yinghu Hu

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 4 EPO patents. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2019-2021.

USPTO Granted Patents = 5 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 6.6

ph-index = 1

Company Filing History:

5 out of 121

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

patents

Years Active: 2019-2021

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10947245 - Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine for inhibiting toll-like receptor activity (2021-03-16),

2. 10780091 - TLR7 agonist maleate salt, crystalline forms C, D and E thereof, preparation methods and uses of maleate salt and crystalline forms (2020-09-22),

3. 10683296 - TLR7 agonist trifluoroacetate salt and crystalline form B thereof, preparation methods and uses (2020-06-16),

4. 10654856 - Method for preparing pyrrolo[3,2-D]pyrimidine compound, and intermediates thereof (2020-05-19),

5. 10442811 - Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D] pyrimidin-4-amine, preparation process and use thereof (2019-10-15),

Title: Innovations of Yinghu Hu

Introduction

Yinghu Hu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target toll-like receptors. With a total of five patents to his name, his work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Yinghu Hu's latest patents include a crystalline form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine, which is designed for inhibiting toll-like receptor activity. This invention details the preparation method for this crystalline form and its applications. Another notable patent involves a maleate salt of the same compound, along with crystalline forms C, D, and E. This patent outlines the preparation methods, pharmaceutical compositions, and various uses of these crystalline forms.

Career Highlights

Yinghu Hu is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a focus on enhancing the efficacy of treatments through novel compounds.

Collaborations

Yinghu Hu collaborates with esteemed colleagues such as Zhaozhong Ding and Fei Sun, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yinghu Hu's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in medical treatments.